Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease

Published 2016 View Full Article

Authors

Keywords

Huntington's disease, Monoamine oxidase, Monoamine oxidase inhibitors, Mouse model, Psychiatric features, Depression, Anxiety, Monoamines

Journal

EXPERIMENTAL NEUROLOGY

Volume 278, Issue -, Pages 4-10

Publisher

Elsevier BV

Online

2016-01-26

DOI

10.1016/j.expneurol.2016.01.019

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started